CFD and type 2 diabetes mellitus: Because many clinical parameters differed significantly between the normal glycemia and other groups, we focused on the two diabetic groups including the T2D-w/o-insulin and the T2D-with-insulin groups to determine whether plasma adipsin concentrations could reflect changes in beta cell function.